A study of antibiogram assay, risk factors and etiology of ventilator associated pneumonia (VAP) in a tertiary care hospital of Pakistan Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Epidemiology and outcome of ventilator associated pneumonia in an tertiary care ICU of India. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
A study of incidence, outcome and antibiotic sensitivity pattern of ventilator associated pneumonia in icu of tertiary care hospital in Nepal Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Prescription of antibiotics for the treatment of community acquired pneumonia in a district general hospital in the UK Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006
Etiological organisms from patients with hospital acquired pneumonia and its mortality in the respiratory intensive care unit Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007
Factors associated with mortality in community acquired pneumonia at a tertiary care hospital in Pakistan Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Clinical characteristics and antibiotic prescribing in patients admitted with community acquired pneumonia to a university hospital in Pakistan Source: Eur Respir J 2004; 24: Suppl. 48, 242s Year: 2004
Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Pattern of antibiotic resistance in hospital acquired pneumonia in a country where antibiotics are available over the counter without doctors prescription Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
The cost of inpatient care in community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 258s Year: 2005
Nosocomial neonatal pneumonia characteristics in a tertiary children‘s hospital in Iran Source: Annual Congress 2008 - Neonatal intensive care: ventilation and beyond Year: 2008
Effect of adherence to guidelines on mortality, length of stay and critical care admission in community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Effect of giving antibiotics within 4 hours to patients with community-acquired pneumonia on mortality, length of stay and critical care admission Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Causative organisms in ventilator associated pneumonia patients from a tertiary center in south India Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010
Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
Studying the association between mortality in patients requiring hospital admission for Community Acquired Pneumonia and pre-hospital antibiotic treatment in primary care Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Moscow city hospital Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021
Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014